Showing 1871-1880 of 7448 results for "".
Zooming In on Gen Z Skin Care Challenges—Behaviors to Grow Your Practice
https://practicaldermatology.com/topics/practice-management/zooming-in-on-gen-z-skin-care-challenges-behaviors-to-grow-your-practice/23960/Aligning your efforts to connect with Gen Z is critical for growing your practice.Connective Tissue Disorders Update 2025: Dr. Vleugels
https://practicaldermatology.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.A Case Study in Selling a Dermatology Practice
https://practicaldermatology.com/topics/practice-management/a-case-study-in-selling-a-dermatology-practice/27166/Clint Bundy, an M&A advisor specializing in physician practices, talks with Dr. Alison Moon, a distinguished physician and former owner of First Coast Dermatology, about the process of the sale of her practice.Breaking the Itch-Scratch Cycle
https://practicaldermatology.com/topics/atopic-dermatitis/breaking-the-itch-scratch-cycle/23922/Upadacitinib’s rapid relief for patients with moderate-to-severe atopic dermatitis.Dermatologists and Rosacea Patients as Partners: A Quest for Clear Skin
https://practicaldermatology.com/topics/acne-rosacea/dermatologists-and-rosacea-patients-as-partners-a-quest-for-clear-skin/23730/It is possible to achieve and maintain remission of rosacea.Slimming the Masseters with Neuromodulator Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/slimming-the-masseters-with-neuromodulator-injections/23648/Demand for this minimally-invasive and effective intervention is growing. Success depends on proper training and administration.Biologics in Pediatric Dermatology
https://practicaldermatology.com/topics/psoriasis/biologics-in-pediatric-dermatology/23198/Younger patients are finally gaining access to a range of highly targeted treatments with lower risk profiles than their traditional alternatives.Use Instagram to Promote Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/use-instagram-to-promote-your-dermatology-practice/20351/Instagram can help a practice promote products and services without incurring significant expenses for advertising.One-and-Done Tattoo Removal: Is It Possible With Q-switched Technology?
https://practicaldermatology.com/topics/practice-management/one-and-done-tattoo-removal-is-it-possible-with-q-switched-technology/21019/Newer and more powerful nanosecond lasers coupled with improved techniques have greatly improved the ability to clear tattoos faster and treat resistant colors.The Impact of Clascoterone Topical Cream, 1%
https://practicaldermatology.com/issues/april-2025/the-impact-of-clascoterone-topical-cream-1/35605/Clascoterone topical cream, 1% (Winlevi, Sun Pharmaceuticals, Inc.) approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older.